Schildkraut, Mark

Mark Schildkraut is Associate General Counsel-IP at Becton, Dickinson and Company (BD), a Fortune 500 medical technology company advancing the world of health by improving medical discovery, diagnostics and the delivery of care.

Mark has responsibility for and leads a team of IP associates that handles intellectual property matters concerning the business units within BD’s Medical Segment (~$9.5 billion in annual revenue).  These matters include patent, trade secret and trademark protection, drafting and negotiating technology and commercial agreements, product clearance, litigation and client counseling. 

Mark is also responsible for establishing legal strategy and counsel on trade secrets as well as enforcement issues relating to the infiltration of BD’s information network and product offerings and exfiltration of BD’s sensitive information.  Particularly noteworthy was Mark’s involvement in BD v. Maniar and US v. Maniar, resulting in the guilty plea of two counts of theft and attempted theft of trade secrets.  He has also been involved with criminal prosecutions in Utah and Illinois, as well as civil enforcement in California and China.

Mark has been an associate with BD’s Legal Department since 2005. 

Prior to joining BD, Mark was an associate at New York law firm’s Kaye Scholer LLP (now Arnold & Porter) and Morgan & Finnegan LLP, focusing on patent litigation, IP clearance and prosecution matters.  Mark received his J.D. from Fordham University’s School of Law and a B.S. in Electrical Engineering from the State University of New York at Buffalo.   He is currently studying for his Masters of Law in Information Technology Law from the University of Edinburgh School of Law.